Menu

Oncotelic Therapeutics, Inc. OTLC

Full chart Compare
Set alert

Price alert · OTLC

All alert types
0.01 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

0.0129 Day range 0.0135
0.01 52-week range 0.10
YTD
-87.50%
1 year
-90.00%

Revenue & Expenses

Revenue → Gross Profit: $70.00KGross Profit → Expenses: $70.00KExpenses → Selling, General & Admin: $573.73KExpenses → Research & Development: $61.14KExpenses → Other Operating Expenses: $6.08MExpenses → Interest Expense: $1.04MExpenses → Other Expenses: $210.29KNet Loss → Expenses: $7.90MGross Profit$70.00KNet Loss$7.90MExpenses$7.97MSelling, General & Admin$573.73KResearch & Development$61.14KOther Operating Expenses$6.08MInterest Expense$1.04MOther Expenses$210.29KRevenue$70.00K

Latest period ending Dec 31, 2022 · select a line to chart its full history

OTLC annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-9.72M-9.13M-7.58M-4.31M-712.74K
5.09M-9.39M-9.50M-6.64M-712.74K
0.01-0.03-0.11-0.11-0.12
OTLC annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
261.45K588.77K494.02K81.96K2.50K
36.12M23.61M23.66M23.68M2.75M
16.92M15.45M11.18M6.78M283.03K
11.26M8.99M4.65M960.92K0
19.41M7.96M11.77M16.90M2.46M
OTLC annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-1.45M-4.43M-2.81M-2.28M-240.98K
1.13M4.53M3.22M2.17M240.00K
-327.32K94.75K412.06K79.47K-980